SAFE vs. Convertible Note vs. Priced Round: How to Choose

The Short Version

There are three ways to structure an early-stage investment: a SAFE (Simple Agreement for Future Equity), a convertible note, or a priced round. Each has different mechanics, different implications for your cap table, and different consequences for your relationship with investors. The right choice depends on what you want the company to become and which investors’ return expectations align with yours.

Most guides explain what each instrument is. This guide explains when to use each one, why, and what happens when the choice goes wrong.

Why the Instrument Matters Less Than the Strategy

Before getting into the mechanics, here is the thing that most guides skip: the financial instrument is a tool in a larger fundraising strategy. The real questions are:

How much capital does the business need to reach a meaningful milestone?
What type of investors are you raising from, and what are their return expectations?
What does the cap table look like after this round and the next one?
Are you raising on a rolling close or coordinating a single close?

SAFEs, convertible notes, and priced rounds are different ways to answer these questions. Choosing the right instrument means thinking ahead as far as you can see and gaming out different growth and funding scenarios.

Founders should always look for investors who are value-add, meaning each investor unlocks something for the business or can function as a second brain for the leadership team. That might be channel partnerships, domain expertise, technical knowledge, or professional networks in insurance, legal, or regulatory areas that are critical to the business. The financial instrument should reflect the founder’s best expectation of growth trajectory, the investors’ return expectations, and where the economy sits in terms of interest rates and cost of capital.

The Three Instruments

SAFE (Simple Agreement for Future Equity)

A SAFE is not debt. It’s not equity. It’s a contract that gives the investor the right to receive equity in the future, typically when you raise a priced round. Carolynn Levy, General Counsel at Y Combinator, created the SAFE in 2013 to simplify seed-stage fundraising. Her argument was philosophical: venture capital should be based on equity, not debt, and the 13-page convertible note was needlessly adversarial for a $125K investment. The 5-page SAFE replaced all of that complexity.

The SAFE has become the dominant instrument for pre-seed and seed rounds. Carta’s data shows that by Q4 2025, SAFEs accounted for 93% of early-stage instruments on their platform, with $13.5 billion raised via SAFEs in 2025 alone (up from $3.5 billion in 2021).

How it works:

You and an investor agree on a valuation cap (the maximum valuation at which their investment converts to equity) and sometimes a discount (a percentage discount to the price per share in the next round). The investor wires money. No shares have been issued. Interest does not accrue. There is no maturity date. The SAFE sits on your cap table as an obligation until a conversion event triggers it.

Example:

An investor puts in $500K on a SAFE with a $5M cap. You later raise a Series A at a $10M pre-money valuation.

The SAFE converts at the cap of $5 million, not at the Series A price of $10 million. The investor’s $500K buys equity as if the company were worth $5M, giving them 10% of the company at conversion ($500K / $5M). If the Series A had come in at $4M pre-money (below the cap), the SAFE would convert at $4M, giving the investor 12.5%.

Pre-money vs. post-money SAFEs:

This distinction matters more than most founders realize. Y Combinator updated the standard SAFE in 2018 to be “post-money,” meaning the cap represents the company’s value including the SAFE investment itself.

Pre-money SAFE with $5M cap: Investor’s ownership = $500K / ($5M + $500K) = 9.1% Post-money SAFE with $5M cap: Investor’s ownership = $500K / $5M = 10.0%

The difference seems small on one SAFE. But if you raise $2M on post-money SAFEs with a $5M cap, those investors own 40% of the company before the priced round even happens. Many founders don’t model this until it’s too late.

Post-money SAFEs have become the standard, but they are more investor-favorable than the original pre-money version. Understand which version you are signing and model the dilution before you agree to terms.

Convertible Note

A convertible note is debt that converts to equity. Unlike a SAFE, it has an interest rate and a maturity date. If the note matures before a conversion event, the investor can technically demand repayment (though this rarely happens as it would likely bankrupt the company).

How it works:

The investor lends you money. The note accrues interest (typically 4-8% annually). It has a maturity date (typically 18-24 months). When you raise a priced round, the principal plus accrued interest converts to equity at either the valuation cap or a discount to the round price, whichever gives the investor a better deal.

Example:

An investor puts in $500K on a convertible note with a $5M cap, 6% interest, and an 18-month maturity. After 12 months, you raise a Series A at $10M pre-money.

Accrued interest: $500K x 6% x 1 year = $30K Total converting: $530K Conversion price: based on $5M cap (since that’s better for the investor than the $10M round price) Investor’s ownership: $530K / $5M = 10.6%

The extra 0.6% comes from the interest. Over longer periods, this adds up. A note outstanding for 2 years at 8% interest means the investor is converting 16% more than their original investment.

When does the maturity date matter?

In theory, if you haven’t raised a priced round by the maturity date, the investor can demand repayment. This almost never happens because demanding repayment would bankrupt the company, and the investor would lose everything. Most investors extend the maturity rather than force the issue.

But it creates leverage. An investor with a maturing note can negotiate new terms (a lower cap, a higher interest rate, board rights) as a condition of extending it. Therefore, SAFEs, which have no maturity date, have largely replaced notes for founder-friendly seed rounds.

That said, in my experience, more traditional angel investors and investors outside the major tech hubs (SF, LA, Austin, NYC) are less comfortable with SAFEs and prefer convertible notes. The maturity date and interest rate give them downside protection that a SAFE does not.

What happens when there’s no priced round coming?

This is a question that matters for profitable, capital-efficient companies that may never raise a traditional venture round. Consider a tech-enabled manufacturer that raises a convertible note to fund a new production line. The business is growing at 20-30% a year, not 3x. There may never be a natural conversion event large enough to deliver the returns the investor expects.

Standard convertible notes define a “qualified financing” trigger, usually a priced round above a certain threshold (often $1M+). If that never happens, the note sits there accruing interest until maturity. At that point, the investor and founder have to negotiate what comes next:

Extend the note and keep accruing interest
Convert to equity at the cap price, giving the investor a minority stake in the company
Repay the principal plus interest (rare, because the company usually can’t afford a lump-sum repayment)

The worst outcome for everyone is a note that sits unconverted for 3+ years because the company is doing well but not raising again. The investor has no liquidity and no equity. The founder has debt on the balance sheet and an unresolved cap table.

For companies that don’t plan to raise a follow-on round, a few alternatives work better than a standard convertible note:

Revenue-based financing, where you repay as a percentage of revenue with no equity given up
A priced equity round at a modest valuation, where you price it now, give the investor their 10-15%, and skip the conversion uncertainty
A convertible note with an explicit conversion trigger tied to a revenue milestone or a specific date, rather than a future priced round that may never come

If you’re building a business that will grow steadily rather than exponentially, think carefully about whether a convertible note is the right instrument. The conversion mechanics need to make sense for how the company will actually grow, not how a venture-backed startup would grow.

Priced Round (Equity)

A priced round is the “real” equity transaction. You negotiate a valuation, issue shares (usually preferred stock), and the investors become shareholders with defined rights.

How it works:

You and the lead investor negotiate a pre-money valuation. The investment amount determines the post-money valuation and the investor’s ownership percentage.

Example:

Pre-money valuation: $8M Investment: $2M Post-money valuation: $10M Investor ownership: $2M / $10M = 20%

The investor receives preferred stock with specific rights defined in the term sheet: liquidation preference, board seats, anti-dilution protection, pro rata rights, and information rights. These rights don’t exist with SAFEs or notes (until conversion).

The cost:

A priced round is significantly more expensive to execute. Legal fees typically run $30-50K for the company (plus the investor’s legal fees, which you usually also pay). The company can complete a SAFE for $0-5K in legal fees. A convertible note falls somewhere in between.

The additional cost buys clarity: everyone knows exactly how much they own, what rights they have, and what the company is worth.

A Cautionary Tale About Convertible Stacking

I previously worked for a startup that ran into serious trouble because they raised too many convertible instruments over a three-year period. The company could not get traction with institutional VCs, so the founder raised on a series of convertible notes from angels and smaller investors. When they finally secured one equity investor, everything converted. On paper, it looked like the company had raised significant capital, but the only new cash coming in was from the small-priced equity round. The company had already spent the cash from the previous notes.

The outcome was that the company ran out of runway. The core issue was not the choice of instrument. It was that the company inadequately planned its burn rate and was idealistic instead of realistic about traction and the revenue model. The business was not on a path to sustainability and profitability. Investment cash seeks ROI. It is not a charity.

The lesson: convertibles and SAFEs make sense when they serve an obvious purpose, like funding a specific milestone that positions the company for a larger raise. They become dangerous if they replace a real fundraising strategy or if they fund a company without product-market fit.

The Rolling Close and Tranching Strategy

SAFEs and convertible notes allow for rolling closes, where you accept investments from different investors over a period instead of coordinating a single close. This is one of their biggest advantages over priced rounds.

There is an art to running a rolling close well. Investors want to see markups between rounds. Even in a rolling close over a 12-month period, a fast-growing startup should show external signs of progress and communicate a story of increasing valuation.

For instance, investors might arrange a $1.5M raise using 2-3 segments with minor variations in valuation caps, spaced six months apart for fundraising efforts. When the company has a prototype and early customers, the first $500K closes at a $4M cap. A key partnership or revenue milestone will trigger the closure of the next $500K at a $5M cap. The final $500K closes at a $6M cap as the company approaches the metrics needed for a priced Series A.

Each tranche rewards earlier investors for taking more risk (they get a lower cap) while reflecting the company’s increasing value. This approach also creates natural urgency: investors considering the current tranche know the cap will go up in the next one.

For non-venture small businesses (tech-enabled manufacturers, profitable but cash-poor DTC or CPG companies), the considerations are distinct. A convertible note or SAFE needs a conversion trigger that makes sense for the business. It is a poor outcome for an investor who backs a high-potential company only to get back their money after 18 months at what amounts to a moderately high interest rate. These investors are investing for equity, not debt. Debt is a bridge mechanism that allows the company to grow quickly without having to pay for a priced round in terms of founder time, legal fees, and before the company is ready for a lead investor.

A smaller company might fill a round with 1-3 strategic investors from their industry. To do that, founders need to think through the mechanics of how those investors get paid back and what their return expectations are. In my experience, and this is a broad generalization, these smaller investors are looking for a 3-5x multiple on their investment over 3-7 years. An investor writing a $100K check is hoping for roughly $500K back in 5 years (approximately 38% IRR, which is very, very good). Those return expectations should be accounted for in the valuation discussion.

The Decision Framework

Use a SAFE when:

You’re raising pre-seed or seed from angels in the tech ecosystem. SAFEs are fast, cheap, and standard. Angels in SF, LA, Austin, and NYC expect them. You can close individual investors in weeks rather than months.

You want to raise from multiple investors over time. SAFEs let you accept money as it comes in without coordinating a single close. Investor A signed in January, Investor B signed in March, and Investor C signed in May. Each gets the same (or different) terms.

You don’t want to set a valuation yet. If you’re too early to justify a specific valuation, a SAFE with a cap lets you defer the pricing until you have more traction.

Speed matters. SAFEs are 5-10 pages long. A priced round term sheet plus all the ancillary documents is 50+ pages. If you need money fast, SAFEs close faster.

Use a convertible note when:

The investor requires it. Some institutional investors and family offices are required to hold debt instruments rather than equity. A convertible note gives them debt characteristics (interest, maturity) while still providing equity upside. Similarly, more traditional business angels are more comfortable with the terms of a Note than a SAFE. If that is your only source of capital, then you must play by their rules.

You’re raising outside the major tech hubs. SAFEs are less well understood outside the US tech ecosystem. Convertible notes have been around longer and have more established legal frameworks internationally and with more traditional investors.

You want the interest to compensate early investors. If you’re raising a small amount and the priced round is 18+ months away, accrued interest gives early investors a modest premium for taking the earliest risk.

Use a priced round when:

You have a lead investor who wants to price it. At Series A and beyond, priced rounds are standard because investors want defined rights (board seats, anti-dilution protection) that don’t exist with SAFEs.

You’ve raised enough on SAFEs/notes that the cap table is getting complex. If you have 5+ SAFEs outstanding at different caps, the conversion math is difficult to model. A priced round cleans this up by converting everything at once.

You want certainty. Everyone knows exactly what they own. There is no conversion uncertainty. No modeling needed.

You have enough traction to justify a valuation. If you can defend a specific valuation with data (revenue, growth rate, comparable companies), a priced round lets you capture that value explicitly.

Fred Wilson, co-founder of Union Square Ventures, has argued consistently that founders should do priced rounds from the start. His concern: notes and SAFEs build up like a house of cards, and founders don’t realize how much dilution they’ve taken until a priced round forces the conversion. He recommends founders insist their lawyers publish a pro forma cap table at the closing of every note, showing ownership at different conversion prices.

The Math Founders Miss

Stacking SAFEs

The most dangerous scenario is raising multiple SAFEs at different caps without modeling the cumulative dilution.

Scenario:

SAFE 1: $250K at $4M post-money cap
SAFE 2: $500K at $5M post-money cap
SAFE 3: $250K at $6M post-money cap
Series A: $2M at $10M pre-money, with a 10% option pool

Before the Series A, the SAFEs convert:

SAFE 1: $250K / $4M = 6.25%
SAFE 2: $500K / $5M = 10.0%
SAFE 3: $250K / $6M = 4.17%
Total SAFE dilution: 20.42%

Then the Series A:

New investor: $2M / ($10M + $2M) = 16.67%
Option pool: 10%

Founder ownership after all conversions: roughly 53% (before the round) becomes roughly 42% after the round and pool.

If both co-founders started at 50/50, each co-founder now owns approximately 21%.

Many founders don’t run this math until the Series A term sheet arrives. By then, it’s too late to renegotiate the SAFEs.

The option pool shuffle

Investors in a priced round almost always require a new or refreshed option pool, typically 10-15% of post-money shares. The company creates this pool pre-money, so it dilutes existing shareholders (founders and SAFE/note holders), not the new investor.

This is one of the most significant sources of hidden dilution. A 10% option pool on a $10M pre-money round effectively reduces the pre-money valuation by $1M from the founders’ perspective. Negotiate the pool size. If you’ve already made key hires and don’t need a large pool, push for 7-8% instead of 15%.

What to Negotiate

Regardless of instrument, here are the terms that matter most:

Valuation cap (SAFEs/notes). The most important term. It determines how much of the company the investor gets when they convert. Lower cap = more dilution for you. The cap should reflect your best expectation of growth trajectory, balanced against the risk the investor is taking and the valuation expectations of your next investors. Some investors will invest in an uncapped note just to get into a hot round, but that’s more the exception than the rule.

Discount rate (SAFEs/notes). Typically 15-25%. Gives the investor a discount to the next round’s price. Less impactful than the cap unless the next round’s valuation is close to the cap.

Pro rata rights. The right for investors to maintain their ownership percentage in future rounds by investing more. Standard and reasonable.

MFN (Most Favored Nation). A clause stating that if you issue a subsequent SAFE with better terms, the earlier investor automatically gets those better terms. Common and fair.

Information rights. The investor’s right to see your financial statements. Standard at any level.

Board seats. Not relevant for SAFEs or notes. At the seed stage, a common structure is 2 founder seats + 1 investor seat. At Series A, it might shift to 2 founder + 2 investor + 1 independent.

Liquidation preference. In a priced round, this determines who gets paid first if the company is sold. A 1x non-participating preference is standard and fair: the investor gets their money back before common shareholders, but nothing more beyond their equity stake. Carta’s data confirms this is the norm: only 3.1% of Seed and Series A deals in 2025 had liquidation preferences above 1x. If an investor is asking for more, they are outside market terms and you should push back.

Warrants. A warrant is the right to purchase shares at a fixed price in the future. Sometimes people attach them to convertible notes to give investors additional upside beyond the conversion terms. For instance, an investor might receive a convertible note plus warrants to purchase an additional $50K worth of shares at the note’s cap price. Warrants are more common with traditional or strategic investors and in deals where the investor is providing something beyond capital (a strategic partnership, distribution access, or significant advisory value).

Preferred return. In some structures, particularly with family offices and strategic investors, the investor may negotiate a preferred return, a guaranteed annual return (often 6-10%) that accrues before any other distributions. This is more common in private equity and real estate than in venture, but it appears in deals with non-institutional investors who want downside protection. Founders should understand how preferred returns compound and how they affect the total payout at exit.

The Macro Context

Fundraising terms don’t exist in a vacuum. Interest rates, public market conditions, and the broader economy all affect what investors expect and what founders can negotiate.

During the ZIRP (zero interest rate policy) era, capital was abundant, valuations were high, and SAFEs at generous caps were common. Post-ZIRP, investor expectations around burn rate and path to profitability changed dramatically. A startup that might have raised at a $10M cap in 2021 could raise at a $5M cap in 2024 for the same traction.

The takeaway: fundraising strategy, including instrument choice, valuation, and burn planning, needs to account for where the economy is, not where it was. When money was cheap, a SAFE with a $6M cap made sense, but it might be aggressive now that capital is expensive and investors focus on fundamentals.

The Bottom Line

The instrument you choose is less important than understanding its mechanics and how it fits into your overall fundraising strategy. A SAFE with a $3M cap and a priced round at $3M pre-money give the investor roughly the same ownership. The difference is in the process cost, the speed, the rights attached, and the clarity of the outcome.

Before you sign anything, model the dilution. Know what the cap table looks like after conversion. Understand what the option pool does to your ownership. Make sure the instrument matches the investor’s expectations and your own plans for the company. Think through the conversion triggers, the timeline, and the return expectations of every investor at the table.

And remember: every investor relationship is a partnership. The negotiation on terms, valuation, and instrument should reflect a deal where both sides can succeed. Founders who optimize for the cheapest capital today often pay for it in the next round.

This article reflects my experience working with and investing in startups over the last 10 years. These are generalizations that I offer as rules of thumb, not rules etched in stone. It is not legal or financial advice. Talk to a lawyer before signing anything, and talk to a few other founders before you talk to the lawyer.

SAFE vs. Convertible Note vs. Priced Round: How to Choose

The Short Version

Why the Instrument Matters Less Than the Strategy

The Three Instruments

SAFE (Simple Agreement for Future Equity)

Convertible Note

Priced Round (Equity)

A Cautionary Tale About Convertible Stacking

The Rolling Close and Tranching Strategy

The Decision Framework

Use a SAFE when:

Use a convertible note when:

Use a priced round when:

The Math Founders Miss

Stacking SAFEs

The option pool shuffle

What to Negotiate

The Macro Context

The Bottom Line

Further Reading